Enovix Corp — Director's Dealing 2021

Jul 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Enovix Corp (ENVX)
CIK: 0001828318
Period of Report: 2021-07-14

Reporting Person: HEJLEK EDWARD J (See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-14	Common Stock	A	156921	—	Acquired	156921	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-14	Stock Option (Right to Buy)	$0.0623	A	55383	Acquired	2031-01-06	Common Stock (55383)	Direct
2021-07-14	Stock Option (Right to Buy)	$9.2626	A	46152	Acquired	2031-04-19	Common Stock (46152)	Direct
2021-07-14	Stock Option (Right to Buy)	$6.2626	A	28411	Acquired	2031-04-19	Common Stock (28411)	Direct

Footnotes

F1: Received pursuant to the Agreement and Plan of Merger, dated as of February 22, 2021, by and among Rodgers Silicon Valley Acquisition Corp, a Delaware corporation ("RSVAC"), RSVAC Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of RSVAC ("Merger Sub"), and Enovix Corporation, a Delaware corporation ("Legacy Enovix"), pursuant to which (i) Merger Sub merged with and into Enovix, with Enovix surviving the merger as a wholly owned subsidiary of RSVAC and (ii) RSVAC changed its name to Enovix Corporation.

F2: The shares subject to the option are immediately exercisable. 1/4th of the shares subject to the option vest on the one year anniversary of the vesting commencement date, January 4, 2021, and 1/48th of the shares subject to the option will vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.

F3: Received in exchange for a stock option to purchase 300,000 shares of Legacy Enovix Common Stock.

F4: The shares subject to the option are immediately exercisable and vest in 60 equal monthly installments beginning on the vesting commencement date, April 18, 2021, subject to Reporting Person's continuous service through each such vesting date.

F5: Received in exchange for a stock option to purchase 250,000 shares of Legacy Enovix Common Stock.

F6: The shares subject to the option are immediately exercisable. 1/120th of the shares subject to the option vest monthly over 4 years beginning on the vesting commencement date, April 18, 2021, and 1/20th of the shares subject to the option vest monthly thereafter over the next year, subject to Reporting Person's continuous service through each such vesting date.

F7: Received in exchange for a stock option to purchase 153,900 shares of Legacy Enovix Common Stock.